Novo, Emcure to launch weight-loss drug under new brand in India

In June, Novo Nordisk launched Wegovy (semaglutide) injections in five dosing strengths (0.25, 0.5, 1, 1.7 and 2.4 mg). However, the company has not yet disclosed pricing details for Poviztra. Wegovy is currently priced between ₹17,345 and ₹26,050 across dosages in India. It is prescribed for long-term chronic weight management and reduction in risk of major adverse cardiovascular events (MACE).

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/TrXuex9
via IFTTT